Correction of menopausal symptoms in patients with medical menopause
DOI:
https://doi.org/10.18370/2309-4117.2013.12.36-39Keywords:
agonists of gonadotropin-releasing hormones, endometriosis, phytoestrogens, medical menopause, Lifemin®Abstract
Gonadotropin-releasing hormone agonists (GnRH) used for long-term monotherapy or combination therapy for hormone-dependent tumors. However, their use leads to hypoestrogenism and to all manifestations of menopause. Therefore, patients receiving GnRH therapy, sometimes forced to give it up because of menopause symptoms.
The use of GnRH agonists with phytoestrogens can improve the quality of patients’ life, reducing the negative symptoms of menopause. The study results showed that the treatment of endometriosis by GnRH agonists with phytoestrogen drug Lifemin® almost 5 times reduces the manifestation of psycho-emotional disorders, 8 times reduces vasomotor disorders and improves the skin condition.
References
- Bespalova JV, Volkov NI Evolution of methods of conservative treatment of endometriosis. Gynecology, № 1, Vol. 6. – 2004, 44–46 p
- Serova OF, Titchenko LI New drugs in the treatment of patients with uterine fi broids. Gynecology, № 1, Vol. 1 – 1999, 29–30 p.
- Smetnik VP Premature menopause // Attending physician. – 2004. – № 10. – 8–11 p.
- Smetnik VP, Tumilovich LG Non-operative Gynecology: Guidelines for Physicians. – M. Med. Inform. Agency. – 2005. – 592 p
- Vikhlyaeva EM Gynecological Endocrinology Guidelines. – Moscow: MIA, 2006. – 630–653 p.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2014 И. Н. Сапожак, Ю. П. Богослав
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.